Related Experiment Video
Updated: Feb 3, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
935
Plantar Psoriasis Associated with Olmesartan.
Ons Charfi1,2, Talel Badri2,3, Ghozlane Lakhoua1,2
1National Center Chalbi Belkahia of Pharmacovigilance, 9 Avenue du Dr Zouhaier Essafi 1006, Tunis, Tunisia.
Current Drug Safety
|October 19, 2018
Summary
Drug-induced psoriasis is a known concern. This case highlights olmesartan as a potential trigger for developing plantar psoriasis after prolonged use.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Certain medications can trigger or worsen psoriasis, including lithium, gold salts, beta blockers, and antimalarials.
Observation:
- A case study involving a woman treated with olmesartan for hypertension over three years.
- The patient developed plantar psoriasis.
Findings:
- This report documents an unusual instance of plantar psoriasis.
- Olmesartan was identified as a potential causative agent in this patient.
Implications:
- This case expands the list of medications potentially associated with drug-induced psoriasis.
- Clinicians should consider olmesartan when evaluating new-onset psoriasis, especially in patients with hypertension.
